These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3707637)
1. Cyclosporin A is effective, but not safe, in the management of Behçet's disease. Wechsler B; Mertani EB; le Hoang P; de Groc F; Piette JC; Beaufils H; Aupetit B; le Minh H; Rottembourg J Arthritis Rheum; 1986 Apr; 29(4):574-5. PubMed ID: 3707637 [No Abstract] [Full Text] [Related]
2. [Use of cyclosporin A for the treatment of Behçet's disease]. Alijotas J; Ordi J; Villar M; Biosca M; Marquet R; Vilardell M Presse Med; 1985 Jun; 14(23):1292. PubMed ID: 3160042 [No Abstract] [Full Text] [Related]
4. [Treatment of refractory Behçet's disease with cyclosporin A]. Masuda K Kango Gijutsu; 1985 Mar; 31(4):522-3. PubMed ID: 3846677 [No Abstract] [Full Text] [Related]
5. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Masuda K; Nakajima A; Urayama A; Nakae K; Kogure M; Inaba G Lancet; 1989 May; 1(8647):1093-6. PubMed ID: 2566048 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of skin symptoms of Behçet's disease with low dose cyclosporin A]. Iiyoshi E; Takahashi Y; Sasaki T; Nakajima H Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):877-81. PubMed ID: 2585781 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A treatment of Behçet's disease: a long-term study. Díaz-Llopis M; Cervera M; Menezo JL Curr Eye Res; 1990; 9 Suppl():17-23. PubMed ID: 2384009 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A nephrotoxicity in patients with Behçet's disease. Fukagawa M; Kaname S; Hayashi K; Yamashita H; Masuda K; Kurokawa K Dev Toxicol Environ Sci; 1986; 14():129-33. PubMed ID: 3829971 [No Abstract] [Full Text] [Related]
14. [Cyclosporin A treatment of Behçet's disease]. Büsch R; Ruzicka T; Donhauser G Hautarzt; 1990 Apr; 41(4):229-31. PubMed ID: 2358347 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of cyclosporin therapy for Behçet's disease. Nussenblatt RB; Palestine AG; Chan CC; Mochizuki M; Yancey K Arthritis Rheum; 1985 Jun; 28(6):671-9. PubMed ID: 4004976 [TBL] [Abstract][Full Text] [Related]
17. [Cyclosporin A in the treatment of uveitis in Behçet's disease: apropos of a case]. Annonier P; Brini A Bull Soc Ophtalmol Fr; 1986 Mar; 86(3):305-8. PubMed ID: 3802341 [No Abstract] [Full Text] [Related]
18. Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome. BenEzra D; Cohen E; Chajek T; Friedman G; Pizanti S; de Courten C; Harris W Transplant Proc; 1988 Jun; 20(3 Suppl 4):136-43. PubMed ID: 3381269 [TBL] [Abstract][Full Text] [Related]
19. [Cerebral sinus vein thrombosis in Behçet's disease]. Borer H; Rüttimann S; Kätterer C Schweiz Med Wochenschr; 1991 May; 121(21):788-92. PubMed ID: 2057745 [TBL] [Abstract][Full Text] [Related]
20. The effect of cyclosporin A (CsA) treatment on gingival tissue of patients with Behçet's disease. Pisanty S; Shoshan S; Chajek T; Maftsir G; Sacks B; BenEzra D J Periodontol; 1988 Sep; 59(9):599-603. PubMed ID: 3183921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]